|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Other expense, net | |||||
| Income (loss) from operations before income taxes | |||||
| (Provision for) benefit from income taxes | |||||
| Net income (loss) | |||||
| Net income (loss) per share attributable to common stockholders, basic (in dollars per share) | |||||
| Net income (loss) per share attributable to common stockholders, diluted (in dollars per share) | |||||
| Weighted-average number of shares used in computing net income (loss) per share attributable to common stockholders, basic (in shares) | |||||
| Weighted-average number of shares used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation adjustment | |||||
| Unrealized (loss) gain on marketable securities, net | |||||
| Total comprehensive income (loss) | |||||
Loading...